A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis

NCT04273269 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped The clinical trial is closed due to Lysogene's cessation of activities. This study closure is not due to safety reasons.

Conditions

Interventions

Sponsor

LYSOGENE